首页> 外文期刊>Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology >Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis
【24h】

Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis

机译:attr和Al心脏淀粉样症的不同水平的小微型微钙化和巨噬细胞:用于利用核医学研究对亚型淀粉样症的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Recently, there has been much interest in using nuclear medicine studies to noninvasively identify and subtype cardiac amyloidosis. In particular, modified bone scans using Tc-99m-3,3-diphosphono-1,2-propanodicarboxylic acid (Tc-99m-DPD) and Tc-99m-pyrophosphate (Tc-99m-PYP) are being used to selectively identify patients with ATTR amyloidosis rather than AL amyloidosis. The morphologic basis underlying the selectivity of these imaging modalities for ATTR amyloidosis has been unclear.
机译:背景:最近,利用核医学研究以非侵入性识别和亚型心脏淀粉样症状有兴趣。 特别地,使用使用TC-99M-3,3-二膦酸(TC-99M-DPD)和TC-99M-焦磷酸(TC-99M-PYP)的改性的骨扫描用于选择性地识别患者 有attr淀粉样症而不是Al淀粉样器。 潜在的attr淀粉样病症的这些成像方式的形态学基础尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号